Matches in SemOpenAlex for { <https://semopenalex.org/work/W2364352684> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W2364352684 endingPage "343" @default.
- W2364352684 startingPage "335" @default.
- W2364352684 abstract "As the treatment landscape for advanced melanoma continues to evolve, it is critical to focus on unmet needs and understand the cost of therapy. While Ipilimumab (IPI), an immunotherapy indicated for unresectable advanced melanoma, has been a mainstay of 1st-line treatment, there was no standard of care following progression until recently. The objective of this study was to examine real-world treatment patterns and healthcare costs following IPI use in advanced melanoma patients prior to the anti-PD-1 class approval. Adult stage III or IV melanoma patients treated with IPI were selected between April 1, 2011, and September 30, 2013, from a large U.S. commercial and Medicare claims database. Patients were evaluated for therapy after IPI, with an index date set as the first systemic therapy after IPI. Per-Patient Per-Month (PPPM) healthcare costs while on active treatment were evaluated from index until treatment discontinuation, inpatient death, end of insurance enrollment, or September 30, 2013. Of 361 eligible patients, 111 (30.7%) initiated subsequent systemic therapy (mean age, 57 years; 64.9% male). The most common therapies, single-agent or combination, included vemurafenib (32.4%), paclitaxel (28.8%), temozolomide (20.7%), and carboplatin (17.1%). During a median follow-up of 130 days, mean [standard deviation] PPPM all-cause total healthcare costs were $20,383 [$18,988], of which $4800 (23.6%), $5899 (28.9%), and $9684 (47.5%) were related to melanoma drug costs, medical claims with a diagnosis of melanoma, and other (non-specified) utilization, respectively. When considering total care, the costs of U.S. patients with advanced melanoma post-IPI were substantial across all commonly used agents." @default.
- W2364352684 created "2016-06-24" @default.
- W2364352684 creator A5032397049 @default.
- W2364352684 creator A5058893935 @default.
- W2364352684 creator A5063293001 @default.
- W2364352684 creator A5064227174 @default.
- W2364352684 creator A5067374211 @default.
- W2364352684 creator A5067577806 @default.
- W2364352684 creator A5069118457 @default.
- W2364352684 date "2016-01-01" @default.
- W2364352684 modified "2023-09-27" @default.
- W2364352684 title "Treatment Patterns and Healthcare Costs among U.S. Patients with Advanced Melanoma Initiating Subsequent Systemic Therapy Following Use of Ipilimumab (IPI)" @default.
- W2364352684 cites W1966086758 @default.
- W2364352684 cites W1971941564 @default.
- W2364352684 cites W1979300931 @default.
- W2364352684 cites W2050056063 @default.
- W2364352684 cites W2062937115 @default.
- W2364352684 cites W2097995306 @default.
- W2364352684 cites W2133075384 @default.
- W2364352684 cites W2289338532 @default.
- W2364352684 cites W2326508400 @default.
- W2364352684 cites W1966460987 @default.
- W2364352684 doi "https://doi.org/10.4236/jct.2016.75036" @default.
- W2364352684 hasPublicationYear "2016" @default.
- W2364352684 type Work @default.
- W2364352684 sameAs 2364352684 @default.
- W2364352684 citedByCount "0" @default.
- W2364352684 crossrefType "journal-article" @default.
- W2364352684 hasAuthorship W2364352684A5032397049 @default.
- W2364352684 hasAuthorship W2364352684A5058893935 @default.
- W2364352684 hasAuthorship W2364352684A5063293001 @default.
- W2364352684 hasAuthorship W2364352684A5064227174 @default.
- W2364352684 hasAuthorship W2364352684A5067374211 @default.
- W2364352684 hasAuthorship W2364352684A5067577806 @default.
- W2364352684 hasAuthorship W2364352684A5069118457 @default.
- W2364352684 hasBestOaLocation W23643526841 @default.
- W2364352684 hasConcept C121608353 @default.
- W2364352684 hasConcept C126322002 @default.
- W2364352684 hasConcept C143998085 @default.
- W2364352684 hasConcept C160735492 @default.
- W2364352684 hasConcept C162324750 @default.
- W2364352684 hasConcept C185926286 @default.
- W2364352684 hasConcept C2776131300 @default.
- W2364352684 hasConcept C2776694085 @default.
- W2364352684 hasConcept C2777389519 @default.
- W2364352684 hasConcept C2777658100 @default.
- W2364352684 hasConcept C2777701055 @default.
- W2364352684 hasConcept C2778715236 @default.
- W2364352684 hasConcept C2780964509 @default.
- W2364352684 hasConcept C2781433595 @default.
- W2364352684 hasConcept C2994587330 @default.
- W2364352684 hasConcept C502942594 @default.
- W2364352684 hasConcept C50522688 @default.
- W2364352684 hasConcept C530470458 @default.
- W2364352684 hasConcept C71924100 @default.
- W2364352684 hasConceptScore W2364352684C121608353 @default.
- W2364352684 hasConceptScore W2364352684C126322002 @default.
- W2364352684 hasConceptScore W2364352684C143998085 @default.
- W2364352684 hasConceptScore W2364352684C160735492 @default.
- W2364352684 hasConceptScore W2364352684C162324750 @default.
- W2364352684 hasConceptScore W2364352684C185926286 @default.
- W2364352684 hasConceptScore W2364352684C2776131300 @default.
- W2364352684 hasConceptScore W2364352684C2776694085 @default.
- W2364352684 hasConceptScore W2364352684C2777389519 @default.
- W2364352684 hasConceptScore W2364352684C2777658100 @default.
- W2364352684 hasConceptScore W2364352684C2777701055 @default.
- W2364352684 hasConceptScore W2364352684C2778715236 @default.
- W2364352684 hasConceptScore W2364352684C2780964509 @default.
- W2364352684 hasConceptScore W2364352684C2781433595 @default.
- W2364352684 hasConceptScore W2364352684C2994587330 @default.
- W2364352684 hasConceptScore W2364352684C502942594 @default.
- W2364352684 hasConceptScore W2364352684C50522688 @default.
- W2364352684 hasConceptScore W2364352684C530470458 @default.
- W2364352684 hasConceptScore W2364352684C71924100 @default.
- W2364352684 hasIssue "05" @default.
- W2364352684 hasLocation W23643526841 @default.
- W2364352684 hasOpenAccess W2364352684 @default.
- W2364352684 hasPrimaryLocation W23643526841 @default.
- W2364352684 hasRelatedWork W1488363308 @default.
- W2364352684 hasRelatedWork W1991981189 @default.
- W2364352684 hasRelatedWork W1998772295 @default.
- W2364352684 hasRelatedWork W2005549978 @default.
- W2364352684 hasRelatedWork W2008642727 @default.
- W2364352684 hasRelatedWork W2013001916 @default.
- W2364352684 hasRelatedWork W2057024276 @default.
- W2364352684 hasRelatedWork W2364352684 @default.
- W2364352684 hasRelatedWork W2579054220 @default.
- W2364352684 hasRelatedWork W74659187 @default.
- W2364352684 hasVolume "07" @default.
- W2364352684 isParatext "false" @default.
- W2364352684 isRetracted "false" @default.
- W2364352684 magId "2364352684" @default.
- W2364352684 workType "article" @default.